Delivery Order SPE2DB20D3303-SPE2DB23FA1GL

Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $21,900.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562181192 OTEZLA 30 MG TABLET 60S. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense customers. Amerisourcebergen will deliver the specified medication to a customer located in Conshohocken, Pennsylvania, with performance required between September 14-15, 2023. The Defense...
The Defense Logistics Agency awarded a $140,317.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180632 OTEZLA 30 MG TABLET 60S. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense components. Amerisourcebergen will deliver the specified tablets to a customer located in Conshohocken, Pennsylvania by September 15, 2023. The Defense Logistics Agency manages the global...
The Defense Logistics Agency awarded a $8,914.13 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 4561806171 OTEZLA 30 MG TABLET 60S. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the prime contractor, Amerisourcebergen Drug Corporation, to deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 15, 2023 in support of the Defense Logistics...
The Defense Logistics Agency awarded a $60,347.94 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561708831 OTEZLA 30 MG TABLET 60S. The place of performance is Conshohocken, Pennsylvania. The order period of performance is from August 4, 2023 through August 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order requirements as the prime contractor. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $37,074.83 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562102350 OTEZLA 30 MG TABLET 60S. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense customers. Amerisourcebergen will deliver the specified tablets to a customer located in Conshohocken, Pennsylvania, completing performance by September 11, 2023. The Defense Logistics Agency...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $13,374.22 to Amerisourcebergen Drug Corporation for the supply of 4562049013 OTEZLA 30 MG TABLET 60S. The place of performance is Conshohocken, Pennsylvania. The delivery order period of performance is September 5-6, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor. No major subcontractors or set aside designations were...
The Defense Logistics Agency awarded a delivery order valued at $3,781.84 to Amerisourcebergen Drug Corporation to supply 4562099737 OTEZLA 30 MG TABLETS, 60 count per package. The order is for firm fixed price delivery of the pharmaceutical product to a facility located in Conshohocken, Pennsylvania, with performance required between September 8-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No...
The Defense Logistics Agency Troop Support Medical awarded a $1,648.32 firm fixed price delivery order to Amerisourcebergen Drug Corp for OTEZLA 30 MG tablets. The order is for 60 tablets and is to be delivered to a location in Conshohocken, Pennsylvania by October 12, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor. No set-aside designation was used for this order, which is being fulfilled under an existing contract...
The Defense Logistics Agency awarded a $103,678.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OTEZLA 30 MG tablets. Under this order, Amerisourcebergen will deliver 60 tablets of OTEZLA to a location in Conshohocken, Pennsylvania by September 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support the resupply of military services and coalition partners. This delivery order was awarded utilizing an...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $24,673.53 to Amerisourcebergen Drug Corporation for the provision of 4561356062 OTEZLA 30 MG TABLET 60S. The place of performance is Conshohocken, Pennsylvania. The order period of performance is from June 27, 2023 through June 28, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FA1GL
    Delivery Order

The Defense Logistics Agency awarded a $12,809.83 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562114299 OTEZLA 30 MG TABLET 60S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located there. Funding is provided by the Defense Logistics Agency to support its logistics and procurement missions. No set aside designation or subcontractors are indicated. The delivery order has a period of performance from September 11-12, 2023 to provide the requested pharmaceutical product in support of DLA programs.

Generated 12/17/23, 11:03 PM